MiRNA Molecular profiles in human medical conditions: Connecting lung cancer and lung development phenomena

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 22, 2014, Pages 9557-9565

  Aghanoori, Mohamad Reza ^a   Mirzaei, Behnaz ^b   Tavallaei, Mahmood ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lung cancer; Lung development; Medical conditions; miRNA

Indexed keywords

EID: 84921498018     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.22.9557     Document Type: Review

References (102)

1. Akcakaya P, Ekelund S, Kolosenko I, et al (2011). miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol, 39, 311-8.
2. Almeida MI, Reis RM, Calin GA (2011). MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res, 717, 1-8.
3. Alsaleh G, Suffert G, Semaan N, et al (2009). Bruton's tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes. J Immunol, 182, 5088-97.
4. Ambros V (2004). The functions of animal microRNAs. Nature, 431, 350-5.
5. Bahl A, Sharma DN, Rath GK, et al (2008). Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury. In regard to Anscher MS et al. (Int J Radiat Oncol Biol Phys 2008;71:1-9). Int J Radiat Oncol Biol Phys, 72, 630.
6. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
7. Bhaskaran M, Wang Y, Zhang H, et al (2009). MicroRNA-127 modulates fetal lung development. Physiol Genomics, 37, 268-78.
8. Boehm M, Slack F (2005). A developmental timing microRNA and its target regulate life span in C. elegans. Science, 310, 1954-7.
9. Bueno MJ, Perez de Castro I, Malumbres M (2008). Control of cell proliferation pathways by microRNAs. Cell Cycle, 7, 3143-8.
10. Cai X, Hagedorn CH, Cullen BR (2004). Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA, 10, 1957-66.
11. Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66.
12. Calin GA, Dumitru CD, Shimizu M, et al (2002). Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA, 99, 15524-9.
13. Calin GA, Sevignani C, Dumitru CD, et al (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA, 101, 2999-3004.
14. Chen K, Rajewsky N (2007). The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet, 8, 93-103.
15. Chen X, Hu Z, Wang W, et al (2012). Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer, 130, 1620-8.
16. Chen Z, Xu L, Ye X, et al (2013). Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic review. PLoS One, 8, 61008.
17. Dai Y, Huang YS, Tang M, et al (2007). Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus, 16, 939-46.
18. Dai Y, Sui W, Lan H, et al (2009). Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int, 29, 749-54.
19. de Pontual L, Yao E, Callier P, et al (2011). Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nat Genet, 43, 1026-30.
20. Dews M, Homayouni A, Yu D, et al (2006). Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet, 38, 1060-5.
21. Doench JG, Sharp PA (2004). Specificity of microRNA target selection in translational repression. Genes Dev, 18, 504-11.
22. Dong J, Jiang G, Asmann YW, et al (2010). MicroRNA networks in mouse lung organogenesis. PLoS One, 5, 10854.
23. Du L, Pertsemlidis A (2012). microRNA regulation of cell viability and drug sensitivity in lung cancer. Expert Opin Biol Ther, 12, 1221-39.
24. Esau C, Kang X, Peralta E, et al (2004). MicroRNA-143 regulates adipocyte differentiation. J Biol Chem, 279, 52361-5.
25. Fassina A, Cappellesso R, Fassan M (2011). Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. Chest, 140, 1305-11.
26. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 9, 102-14.
27. Fulci V, Scappucci G, Sebastiani GD, et al (2010). miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol, 71, 206-11.
28. Gao W, Xu J, Shu YQ (2011). miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer. Expert Rev Respir Med, 5, 699-709.
29. Gregory PA, Bert AG, Paterson EL, et al (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 10, 593-601.
30. Gregory RI, Shiekhattar R (2005). MicroRNA biogenesis and cancer. Cancer Res, 65, 3509-12.
31. Grosshans H, Slack FJ (2002). Micro-RNAs: small is plentiful. J Cell Biol, 156, 17-21.
32. Guan P, Yin Z, Li X, et al (2012). Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J Exp Clin Cancer Res, 31, 54.
33. Guo Q, Wang F, Lu CQ, et al (2007). The expression of transforming growth factor beta1 and its I, II receptors in the development of rat embryo and embryonic lung. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 23, 317-9 (in Chinese).
34. He F, Zheng LL, Luo WT, et al (2014). Inferring single nucleotide polymorphisms in microRNA binding sites of lung cancer-related infammatory genes. Asian Pac J Cancer Prev, 15, 3601-6.
35. He L, Hannon GJ (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet, 5, 522-31.
36. Herbst RS, Heymach JV, Lippman SM (2008). Lung cancer. New Engl J Med, 359, 1367-80.
37. Hu Z, Chen X, Zhao Y, et al (2010). Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol, 28, 1721-6.
38. Hu Z, Shu Y, Chen Y, et al (2011). Genetic polymorphisms in the precursor MicroRNA flanking region and non-small cell lung cancer survival. Am J Respir Crit Care Med, 183, 641-8.
39. Hughes AE, Bradley DT, Campbell M, et al (2011). Mutation altering the miR-184 seed region causes familial keratoconus with cataract. Am J Hum Genet, 89, 628-33.
40. Hugon J, Paquet C (2008). Targeting miRNAs in alzheimer's disease. Expert Rev Neurother, 8, 1615-6.
41. Johnson SM, Grosshans H, Shingara J, et al (2005). RAS is regulated by the let-7 microRNA family. Cell, 120, 635-47.
42. Joshi S, Kotecha S (2007). Lung growth and development. Early Hum Dev, 83, 789-94.
43. Keller A, Leidinger P, Gislefoss R, et al (2011). Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol, 8, 506-16.
44. Kesanakurti D, Maddirela DR, Chittivelu S, et al (2013). Suppression of tumor cell invasiveness and in vivo tumor growth by microRNA-874 in non-small cell lung cancer. Biochem Biophys Res Commun, 434, 627-33.
45. Kozuki T, Hisamoto A, Tabata M, et al (2007). Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung. Lung Cancer, 58, 30-5.
46. Kumar MS, Erkeland SJ, Pester RE, et al (2008). Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA, 105, 3903-8.
47. Lai EC, Tomancak P, Williams RW, et al (2003). Computational identification of Drosophila microRNA genes. Genome Biol, 4, 42.
48. Lee RC, Feinbaum RL, Ambros V (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-54.
49. Lee Y, Ahn C, Han J, et al (2003). The nuclear RNase III Drosha initiates microRNA processing. Nature, 425, 415-9.
50. Lee Y, Jeon K, Lee JT, et al (2002). MicroRNA maturation: stepwise processing and subcellular localization. EMBO J, 21, 4663-70.
51. Lee YS, Dutta A (2007). The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev, 21, 1025-30.
52. Li Y, Zhang D, Chen C, et al (2012). MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. Mol Biol Cell, 23, 1423-34.
53. Lim LP, Lau NC, Garrett-Engele P, et al (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-73.
54. Lin CW, Chang YL, Chang YC, et al (2013). MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun, 4, 1877.
55. Lin PY, Yang PC (2011). Circulating miRNA signature for early diagnosis of lung cancer. EMBO Mol Med, 3, 436-7.
56. Liu J, Lu KH, Liu ZL, et al (2012a). MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. BMC Cancer, 12, 519.
57. Liu L, Shao X, Gao W, et al (2012b). MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor. FEBS J, 279, 3800-12.
58. Liu X, Sempere LF, Ouyang H, et al (2010). MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest, 120, 1298-309.
59. Liu XH, Lu KH, Wang KM, et al (2012c). MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. BMC Cancer, 12, 348.
60. Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.
61. Lu Y, Okubo T, Rawlins E, et al (2008). Epithelial progenitor cells of the embryonic lung and the role of microRNAs in their proliferation. Proc Am Thorac Soc, 5, 300-4.
62. Lukiw WJ (2007). Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport, 18, 297-300.
63. Lund E, Guttinger S, Calado A, et al (2004). Nuclear export of microRNA precursors. Science, 303, 95-8.
64. Ma L, Teruya-Feldstein J, Weinberg RA (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 449, 682-8.
65. Markou A, Sourvinou I, Vorkas PA, et al (2013). Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung Cancer.
66. Martino S, di Girolamo I, Orlacchio A, et al (2009). MicroRNA implications across neurodevelopment and neuropathology. J Biomed Biotechnol, 2009, 654346.
67. Mattes J, Collison A, Foster PS (2008). Emerging role of microRNAs in disease pathogenesis and strategies for therapeutic modulation. Curr Opin Mol Ther, 10, 150-7.
68. Mencia A, Modamio-Hoybjor S, Redshaw N, et al (2009). Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss. Nat Genet, 41, 609-13.
69. Motsch N, Pfuhl T, Mrazek J, et al (2007). Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol, 4, 131-7.
70. Mraz M, Pospisilova S (2012). MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back. Expert Rev Hematol, 5, 579-81.
71. Mujahid S, Logvinenko T, Volpe MV, et al (2013). miRNA regulated pathways in late stage murine lung development. BMC Dev Biol, 13, 13.
72. Nestle FO, Kaplan DH, Barker J (2009). Psoriasis. N Engl J Med, 361, 496-509.
73. O'Donnell KA, Wentzel EA, Zeller KI, et al (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-43.
74. Pauley KM, Cha S, Chan EK (2009). MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun, 32, 189-94.
75. Rami-Porta R, Crowley JJ, Goldstraw P (2009). The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg, 15, 4-9.
76. Reinhart BJ, Slack FJ, Basson M, et al (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 403, 901-6.
77. Romao JM, Jin W, Dodson MV, et al (2011). MicroRNA regulation in mammalian adipogenesis. Exp Biol Med (Maywood), 236, 997-1004.
78. Saito Y, Liang G, Egger G, et al (2006). Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell, 9, 435-43.
79. Schratt G (2009). microRNAs at the synapse. Nat Rev Neurosci, 10, 842-9.
80. Siomi H, Siomi MC (2010). Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell, 38, 323-32.
81. Skarn M, Namlos HM, Noordhuis P, et al (2012). Adipocyte differentiation of human bone marrow-derived stromal cells is modulated by microRNA-155, microRNA-221, and microRNA-222. Stem Cells Dev, 21, 873-83.
82. Smalheiser NR (2003). EST analyses predict the existence of a population of chimeric microRNA precursor-mRNA transcripts expressed in normal human and mouse tissues. Genome Biol, 4, 403.
83. Sonkoly E, Wei T, Janson PC, et al (2007). MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One, 2, 610.
84. Sun S, Schiller JH, Gazdar AF (2007). Lung cancer in never smokers-a different disease. Nat Rev Cancer, 7, 778-90.
85. Suzuki HI, Yamagata K, Sugimoto K, et al (2009). Modulation of microRNA processing by p53. Nature, 460, 529-33.
86. Tang Y, Liu D, Zhang L, et al (2011). Quantitative analysis of miRNA expression in seven human foetal and adult organs. PLoS One, 6, 28730.
87. Tatsuguchi M, Seok HY, Callis TE, et al (2007). Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol, 42, 1137-41.
88. Thum T, Galuppo P, Wolf C, et al (2007). MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation, 116, 258-67.
89. Tuddenham L, Jung JS, Chane-Woon-Ming B, et al (2012). Small RNA deep sequencing identifies microRNAs and other small noncoding RNAs from human herpesvirus 6B. J Virol, 86, 1638-49.
90. van Rooij E, Sutherland LB, Liu N, et al (2006). A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA, 103, 18255-60.
91. Wang Y, Stricker HM, Gou D, et al (2007). MicroRNA: past and present. Front Biosci, 12, 2316-29.
92. Wu H, Mo YY (2009). Targeting miR-205 in breast cancer. Expert Opin Ther Targets, 13, 1439-48.
93. Xu P, Guo M, Hay BA (2004). MicroRNAs and the regulation of cell death. Trends Genet, 20, 617-24.
94. Xu TP, Zhu CH, Zhang J, et al (2013). MicroRNA-155 expression has prognostic value in patients with non-small cell lung cancer and digestive system carcinomas. APJCP, 14, 7085-90.
95. Yi R, Qin Y, Macara IG, et al (2003). Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev, 17, 3011-6.
96. Yu SL, Chen HY, Chang GC, et al (2008). MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 13, 48-57.
97. Zhang TF, Cheng KW, Shi WY, et al (2012). MiRNA synergistic network construction and enrichment analysis for common target genes in small-cell lung cancer. Asian Pac J Cancer Prev, 13, 6375-8.
98. Zhao Y, Chen X, Jing M, et al (2012). Expression of miRNA-146a in nasopharyngeal carcinoma is upregulated by Epstein-Barr virus latent membrane protein 1. Oncol Rep, 28, 1237-42.
99. Zhao Y, Ransom JF, Li A, et al (2007). Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell, 129, 303-17.
100. Zhao Y, Samal E, Srivastava D (2005). Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 436, 214-20.
101. Zhou YM, Liu J, Sun W (2014). MiR-130a overcomes geftinib resistance by targeting met in non-small cell lung cancer cell lines. Asian Pac J Cancer Prev, 15, 1391-6.
102. Zuo Y, Qiang L, Farmer SR (2006). Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter. J Biol Chem, 281, 7960-7.